Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

The people generally referred to as Negritos were once widely dispersed across South-East Asia. Today, they are found in the ...

Key Insights Stem's significant retail investors ownership suggests that the key decisions are influenced by... SAN FRANCISCO, January 16, 2025--Stem, Inc. (NYSE: STEM), a global leader in ...

Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China ...